Related Articles
Combined inhibition of the EGFR and mTOR pathways in EGFR wild-type non-small cell lung cancer cell lines with different genetic backgrounds
Erastin decreases radioresistance of NSCLC cells partially by inducing GPX4‑mediated ferroptosis
Quinalizarin, a specific CK2 inhibitor, can reduce icotinib resistance in human lung adenocarcinoma cell lines
HIF‑1α inhibits ferroptosis and promotes malignant progression in non‑small cell lung cancer by activating the Hippo‑YAP signalling pathway
Construction of a novel cell-based assay for the evaluation of anti-EGFR drug efficacy against EGFR mutation